Gilead - $25 billion cash available for acquisitionsI looked through Gilead's Q3 release last night and was surprised how much cash they now have available for acquisitions.
With so many great biotech co's beaten down - wouldn't it be great to know who they're looking at!
I'm anticipating the next take-over NR in health care will ignite a rally for the whole sector.